Background: Patients suffering from chronic renal failure have significant challenges in their social and economic lives. In Sudan, the annual incidence of chronic renal failure is between 70 and 140 cases per million, and until more is done to address this illness, the problem is likely to persist. Blood group types appear to be associated with secretor status and certain disorders, in addition to the main therapeutic significance of the ABO blood group to organ transplantation and blood transfusions. Objective: To determine the prevalence of ABO and secretor status, a descriptive cross-sectional study was carried out among Sudanese patients receiving hemodialysis for chronic renal failure disease at the kidney treatment and surgical center in Shendi City between August and December 2021. Materials and Methods: Fifty samples total from patients with chronic renal failure were taken; of these, 42% were female and 58% were male. Two milliliters of venous blood and three milliliters of saliva were collected in sterile containers and EDTA anticoagulant containers, respectively. Slides were used to do ABO grouping, and absorption inhibition was used to determine secretor status. Results: 44% of patients with CKD were blood group O, 38% were blood group A, 16% were blood group B, and 2% were blood group AB. The data also revealed that 68% of patients with CKD were non-secretors and 32% were secretors. According to the study, there was a decrease in the frequency of the Se gene compared to the Se gene. The homozygous genotype SeSe was found to be 3%, the heterozygous genotype Sese to be 29%, and the recessive genotype Sese to be 68%. Additionally, the blood groups O and A have a higher risk of renal failure. Conclusions: Blood group O was the highest frequency among patients receiving hemodialysis for chronic renal failure, followed by blood groups A and B, while blood group AB was the least prevalent. The non-secretors had a higher genotype frequency. Renal failure is more common among non-secretors.